Syros Pharmaceuticals, Inc. - SYRS

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 4/25/2025 10:05:54 PM
EDGAR CIK 0001556263

Buy Breakdown

Total $321,920

Sell Breakdown

Total $76,564

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
11/19/2024
11/20/2024
Quirk Gerald E
Chief Legal & Compliance Offic
Officer
Sell
-46,657 @ $0.22
($10,320.53)
 0 (-100.00%) Direct
11/18/2024
11/20/2024
Chee Conley
President & CEO
CEO Director
Sell
-134,797 @ $0.20
($26,932.44)
 0 (-100.00%) Direct
11/18/2024
11/20/2024
Haas Jason
Chief Financial Officer
CFO
Sell
-137,803 @ $0.21
($28,979.97)
 0 (-100.00%) Direct
11/18/2024
11/20/2024
Roth David
Chief Medical Officer
Officer
Sell
-12,099 @ $0.20
($2,382.29)
 0 (-100.00%) Direct
11/18/2024
11/20/2024
Stephens Kristin
Chief Development Officer
Officer
Sell
-36,133 @ $0.22
($7,949.26)
 0 (-100.00%) Direct
09/12/2024
09/12/2024
Haas Jason
Chief Financial Officer
CFO
Buy
45,344 @ $1.68
$76,005.61
 124,552 (57.25%) Direct
09/11/2024
09/12/2024
Chee Conley
President & CEO
CEO Director
Buy
50,000 @ $1.71
$85,420.00
 122,504 (68.96%) Direct
09/11/2024
09/12/2024
Haas Jason
Chief Financial Officer
CFO
Buy
19,293 @ $1.58
$30,446.28
 79,208 (32.20%) Direct
09/10/2024
09/12/2024
Chee Conley
President & CEO
CEO Director
Buy
50,000 @ $1.51
$75,260.00
 72,504 (222.18%) Direct
09/10/2024
09/12/2024
Haas Jason
Chief Financial Officer
CFO
Buy
35,363 @ $1.55
$54,787.90
 59,915 (144.03%) Direct